NFL Retired Players Association Endorses Halberd Brain Injury Treatment Technology

Source: accesswire.com | Repost Duerson Fund 8/8/2022 – 

Halberd Corporation (OTC PINK:HALB) has received a letter of endorsement from Carl Eller, President of the NFL Retired Players Association (NFL RPA), for Halberd’s research work in the development of treatments for Traumatic Brain Injury (TBI)/chronic traumatic encephalopathy (CTE) sustained by current and retired players. Traumatic brain injuries often progress to neurodegerative diseases, such as PTSD, Alzheimer’s Disease, Parkinson’s Disease, Epilepsy and suicide ideation.

The letter of endorsement from the NFL RPA comes as a result of Halberd’s recent accomplishments demonstrating in-vitro elimination from cerebrospinal fluid (CSF) of multiple key inflammatory cytokines associated with head trauma and many neurodegenerative diseases. Carl Eller has spent the past two years as a consultant to Halberd, following and reviewing Halberd’s development progress towards eliminating excitatory neurotransmitters (inflammatory antigens) resulting from head injuries.

Read the full article…